Page last updated: 2024-09-04

ws 79089b and endothelin-1

ws 79089b has been researched along with endothelin-1 in 8 studies

Compound Research Comparison

Studies
(ws 79089b)
Trials
(ws 79089b)
Recent Studies (post-2010)
(ws 79089b)
Studies
(endothelin-1)
Trials
(endothelin-1)
Recent Studies (post-2010) (endothelin-1)
170112,7406323,394

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (37.50)18.2507
2000's5 (62.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Araki, M; Hasegawa, K; Kaburagi, S; Masaki, T; Morimoto, T; Sasayama, S; Sawamura, T1
Fukai, D; Kinoshita, M; Maeda, Y; Ohnishi, M; Sawaki, M; Tsutamoto, T; Wada, A1
Emoto, N; Ikeda, K; Matsuo, M; Nurhantari, Y; Raharjo, SB; Saiki, K; Yokoyama, M1
Krum, H; Martin, P; Stein-Oakley, A; Tzanidis, A1
Hauss, J; Senninger, N; Spiegel, HU; Uhlmann, D; Witzigmann, H1
Fujii, M; Kinoshita, M; Kurokawa, K; Matsumoto, T; Ohnishi, M; Sawaki, M; Tsutamoto, T; Wada, A; Wang, X; Yamada, H; Yamamoto, T1
Goto, K1
Aberle, NS; Gupta, A; Ren, J; Sharma, AC1

Reviews

1 review(s) available for ws 79089b and endothelin-1

ArticleYear
[Prospects for endothelin-related drugs].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 9

    Topics: Animals; Aspartic Acid Endopeptidases; Bosentan; Cardiovascular Diseases; Drug Design; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-Converting Enzymes; Hemodynamics; Humans; Metalloendopeptidases; Organophosphonates; Peptides, Cyclic; Quinazolines; Receptors, Endothelin; Sulfonamides; Sulfonylurea Compounds; Tetracyclines; Tetrazoles

2004

Other Studies

7 other study(ies) available for ws 79089b and endothelin-1

ArticleYear
The role of endothelin-converting enzyme-1 in the development of alpha1-adrenergic-stimulated hypertrophy in cultured neonatal rat cardiac myocytes.
    Circulation, 1999, Jan-19, Volume: 99, Issue:2

    Topics: Adrenergic alpha-Agonists; Animals; Animals, Newborn; Aspartic Acid Endopeptidases; Atrial Natriuretic Factor; Cells, Cultured; Cricetinae; Endothelin-1; Endothelin-Converting Enzymes; Hypertrophy; Mesocricetus; Metalloendopeptidases; Myocardium; Myosin Heavy Chains; Phenylephrine; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tetracyclines; Transcription, Genetic

1999
Effects of a specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure: comparison of effects with those of endothelin A receptor antagonism.
    Circulation, 1999, Feb-02, Volume: 99, Issue:4

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Azepines; Blood Pressure; Dogs; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Female; Heart; Heart Failure; Hemodynamics; Indoles; Kidney; Male; Neuropeptides; Pulmonary Wedge Pressure; Receptor, Endothelin A; Tetracyclines; Time Factors; Vascular Resistance

1999
Molecular identification and characterization of novel membrane-bound metalloprotease, the soluble secreted form of which hydrolyzes a variety of vasoactive peptides.
    The Journal of biological chemistry, 1999, Nov-05, Volume: 274, Issue:45

    Topics: Alternative Splicing; Amino Acid Sequence; Angiotensin I; Animals; Aspartic Acid Endopeptidases; Atrial Natriuretic Factor; Base Sequence; CHO Cells; Cricetinae; DNA, Complementary; Endothelin-1; Endothelin-Converting Enzymes; Enzyme Inhibitors; Humans; Hydrolysis; Metalloendopeptidases; Mice; Molecular Sequence Data; Solubility; Tetracyclines; Transfection

1999
Effect of a highly selective endothelin-converting enzyme inhibitor on cardiac remodeling in rats after myocardial infarction.
    Journal of cardiovascular pharmacology, 2000, Volume: 36, Issue:5 Suppl 1

    Topics: Animals; Aspartic Acid Endopeptidases; Echocardiography; Endothelin-1; Endothelin-Converting Enzymes; Female; Hemodynamics; Immunohistochemistry; Metalloendopeptidases; Myocardial Infarction; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Tetracyclines; Ventricular Function, Left

2000
Protective role of an endothelin-converting enzyme inhibitor (FR901533) in hepatic ischemia/reperfusion injury.
    Microvascular research, 2001, Volume: 62, Issue:1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aspartic Acid Endopeptidases; Endothelin-1; Female; Hemodynamics; Laser-Doppler Flowmetry; Liver; Liver Circulation; Metalloendopeptidases; Oxygen; Rats; Rats, Wistar; Reperfusion Injury; Tetracyclines

2001
Endothelin-1 promotes vascular structural remodeling during the progression of heart failure prevention of vascular remodeling using a specific endothelin-converting enzyme inhibitor.
    Life sciences, 2001, Oct-12, Volume: 69, Issue:21

    Topics: Animals; Aspartic Acid Endopeptidases; Dogs; Endothelin-1; Endothelin-Converting Enzymes; Endothelium, Vascular; Enzyme Inhibitors; Female; Heart Failure; Hemodynamics; Immunohistochemistry; Male; Metalloendopeptidases; Tetracyclines

2001
Endothelin-converting enzyme-1-mediated signaling in adult rat ventricular myocyte contractility and apoptosis during sepsis.
    Journal of molecular and cellular cardiology, 2005, Volume: 38, Issue:3

    Topics: Animals; Apoptosis; Aspartic Acid Endopeptidases; Caspase 3; Caspases; Endothelin-1; Endothelin-Converting Enzymes; Heart Ventricles; Male; MAP Kinase Signaling System; Metalloendopeptidases; Myocardial Contraction; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Rats; Rats, Sprague-Dawley; Sepsis; Tetracyclines

2005